Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GLS | O94925 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.37 |
| ▸ | APAF1 | O14727 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2764555 | 0.91 | ALDH1A1 (0.39) | ALDH1A1KDM4EGLAHPGDSMN1; SMN2 | |
| Butadiene SCHEMBL2765499 | 0.87 | ALDH1A1 (0.38) | ALDH1A1KDM4EGLAHPGDSMN1; SMN2 | |
| SCHEMBL17853361 | 0.82 | LMNA (0.40) | ALDH1A1KDM4EGLAHPGDSMN1; SMN2 | |
| SCHEMBL2622408 | 0.82 | LMNA (0.40) | ALDH1A1KDM4EGLAHPGDSMN1; SMN2 | |
| SCHEMBL15483099 | 0.80 | ALDH1A1 (0.39) | ALDH1A1KDM4EGLAHPGDSMN1; SMN2 | |
| SCHEMBL18856765 | 0.80 | ALDH1A1 (0.39) | ALDH1A1KDM4EGLAHPGDSMN1; SMN2 | |
| SCHEMBL7693109 | 0.80 | ALDH1A1 (0.41) | ALDH1A1KDM4EGLAHPGDSMN1; SMN2 | |
| SCHEMBL25000888 | 0.78 | ALDH1A1 (0.38) | ALDH1A1KDM4EGLAHPGDSMN1; SMN2 | |
| SCHEMBL11344935 | 0.78 | LMNA (0.42) | ALDH1A1KDM4EGLAHPGDSMN1; SMN2 | |
| SCHEMBL4762440 | 0.78 | ALDH1A1 (0.38) | ALDH1A1KDM4EGLAHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026047173-A1 | PROCESS FOR PREPARING SUSTAINABLE JET FUELS OR DIESEL FUELS; AND PRECURSORS THEREOF | Terra Mater BV (BE) | 2026-03-05 | — | — | WO | claimed |
| EP-4622945-A1 | OLIGOMERISATION OF ALCOHOLS | Terra Mater BV (BE) | 2025-10-01 | — | — | EP | claimed |
| WO-2024110575-A1 | OLIGOMERISATION OF ALCOHOLS | Terra Mater BV (BE) | 2024-05-30 | — | — | WO | claimed |
| EP-2274312-B1 | METAL COMPLEXES | UNIV ZUERICH (CH) | 2015-06-03 | — | — | EP | claimed |
| EP-2708547-A1 | AQUEOUS SOLUTIONS OF RADIOMETAL COMPLEXES WITH TRIDENTATE LIGENDS | Universität Zürich (CH) | 2014-03-19 | — | — | EP | claimed |
| US-20110065680-A1 | Metal Complexes | UNIVERSITY OF ZURICH (CH) | 2011-03-17 | — | — | US | claimed |
| EP-2274312-A2 | METAL COMPLEXES | Universität Zürich (CH) | 2011-01-19 | — | — | EP | claimed |
| WO-2009112823-A2 | METAL COMPLEXES | Universität Zürich (CH) | 2009-09-17 | — | — | WO | claimed |
| WO-2026047173-A1 | PROCESS FOR PREPARING SUSTAINABLE JET FUELS OR DIESEL FUELS; AND PRECURSORS THEREOF | Terra Mater BV (BE) | 2026-03-05 | — | — | WO | disclosed |
| US-12447467-B2 | Borylimide catalysts | SCG Chemicals Public Company Limited (TH) | 2025-10-21 | — | — | US | disclosed |
| EP-4622945-A1 | OLIGOMERISATION OF ALCOHOLS | Terra Mater BV (BE) | 2025-10-01 | — | — | EP | disclosed |
| WO-2024110575-A1 | OLIGOMERISATION OF ALCOHOLS | Terra Mater BV (BE) | 2024-05-30 | — | — | WO | disclosed |
| EP-3656779-B1 | BORYLIMIDE CATALYSTS | SCG CHEMICALS CO LTD (TH) | 2021-10-27 | — | — | EP | disclosed |
| EP-3656779-B1 | BORYLIMIDE CATALYSTS | SCG CHEMICALS CO LTD (TH) | 2021-10-27 | — | — | EP | disclosed |
| US-20030032743-A1 | Catalyst for addition polymerization and process for producing an addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-02-13 | — | — | US | disclosed |
| EP-1266911-A1 | Catalyst for addition polymerization and process for producing an addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-12-18 | — | — | EP | disclosed |
| US-6452017-B1 | THERMALLY STABLE TRISPYRAZOLYLMETHANATE METAL COMPLEXES; CHEMICAL VAPOR DEPOSITION OF SUCH AS BARIUM STRONTIUM TITANATE THIN FILMS ON RANDOM ACCESS MEMORY DEVICES | MICRON TECHNOLOGY, INC. | 2002-09-17 | — | — | US | disclosed |
| US-20020035029-A1 | Catalyst for trimerization of ethylene and process for trimerizing ethylene using the catalyst | TOSOH CORPORATION (JP) | 2002-03-21 | — | — | US | disclosed |
| US-6337297-B1 | CHROMIUM CATALYST FOR TRIMERIZATION OF ETHYLENE WITH MULTIDENTATE LIGAND OR HALOGEN, CARBOXY GROUP | TOSOH CORPORATION (JP) | 2002-01-08 | — | — | US | disclosed |
| US-6133161-A | Methods of forming a film on a substrate using complexes having tris(pyrazolyl) methanate ligands | MICRON TECHNOLOGY, INC. (US) | 2000-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030032743-A1 | Catalyst for addition polymerization and process for producing an addition polymer | BRAP, MCM4, BOLA2; BOLA2B | ALDH1A1 3572/4885KDM4E 2623/4885GLA 3982/4885 |
| US-20110065680-A1 | Metal Complexes | CLTA, L3MBTL3, CLTB | ALDH1A1 4508/4885KDM4E 4837/4885GLA 1705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.